Related Experiment Video
Updated: May 12, 2026
06:02
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
[Hypertrophic cardiomyopathy: current aspects and new developments].
1Hôpital Européen Georges Pompidou, 20, rue Leblanc - 75015 Paris. michel.desnos@egp.aphp.fr
Bulletin De L'Academie Nationale De Medecine
|April 5, 2013
Summary
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition causing thickened heart muscle. It is a leading cause of sudden cardiac death in young individuals, necessitating genetic counseling and risk stratification.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder.
- Diagnosis relies on cardiac imaging like echocardiography and cardiac MRI.
- HCM is the most common inherited cardiovascular disease and a leading cause of sudden cardiac death in young individuals.
Purpose:
- To provide a comprehensive overview of Hypertrophic Cardiomyopathy (HCM).
- To discuss the genetic basis, clinical presentation, diagnosis, and management of HCM.
- To highlight the importance of risk stratification and current treatment strategies.
Summary:
- HCM is an autosomal dominant genetic disorder caused by mutations in sarcomeric protein genes, leading to left ventricular hypertrophy.
- Clinical manifestations range from asymptomatic to severe heart failure, atrial fibrillation, stroke, and sudden cardiac death.
- Management includes medical therapy (beta-blockers, verapamil), interventions for outflow obstruction (alcohol septal ablation, myectomy), and ICD implantation for high-risk patients.
Impact:
- Improved understanding of HCM's genetic underpinnings and clinical spectrum.
- Enhanced diagnostic and risk stratification approaches for HCM patients.
- Informed clinical decision-making for managing HCM and preventing sudden cardiac death.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...